Financials
- Market Capitalization 13.49 M
- Employee 24
- Founded 2003
- CEO Philip A. Serlin
- Website www.biolinerx.com
- Headquarter Israel
- FIGI BBG001Y26LK0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4729 | GTBP GT Biopharma, Inc. - Common Stock | 0.39 USD | -9.30% | -17.02% | -18.75% | -81.78% | 14.06 M USD | ||
| 4730 | QNCX Quince Therapeutics, Inc. - Common Stock | 17.25 USD | -1.65% | +2.19% | +1754.84% | +853.04% | 14.06 M USD | ||
| 4744 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.92 USD | +2.93% | +7.89% | +34.43% | +1390.91% | 13.30 M USD | ||
| 4748 | COCP Cocrystal Pharma, Inc. - Common Stock | 0.96 USD | -4.95% | -6.80% | -3.03% | -44.19% | 13.24 M USD |